成人院外心脏骤停伴难治性休克性心律的肾上腺素管理:来自全国人口登记的时间依赖性倾向评分序列匹配分析

Tasuku Matsuyama, Sho Komukai, Junichi Izawa, Koichiro Gibo, Masashi Okubo, Kosuke Kiyohara, Takeyuki Kiguchi, Taku Iwami, Bon Ohta, Tetsuhisa Kitamura
{"title":"成人院外心脏骤停伴难治性休克性心律的肾上腺素管理:来自全国人口登记的时间依赖性倾向评分序列匹配分析","authors":"Tasuku Matsuyama,&nbsp;Sho Komukai,&nbsp;Junichi Izawa,&nbsp;Koichiro Gibo,&nbsp;Masashi Okubo,&nbsp;Kosuke Kiyohara,&nbsp;Takeyuki Kiguchi,&nbsp;Taku Iwami,&nbsp;Bon Ohta,&nbsp;Tetsuhisa Kitamura","doi":"10.1093/ehjcvp/pvab013","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Little is known about the effect of prehospital epinephrine administration in out-of-hospital cardiac arrest (OHCA) patients with refractory shockable rhythm, for whom initial defibrillation was unsuccessful.</p><p><strong>Methods and results: </strong>This study using Japanese nationwide population-based registry included all adult OHCA patients aged ≥18 years with refractory shockable rhythm between January 2014 and December 2017. Patients with or without epinephrine during cardiac arrest were sequentially matched using a risk set matching based on the time-dependent propensity scores within the same minute. The primary outcome was 1-month survival. The secondary outcomes included 1-month survival with favourable neurological outcome (cerebral performance category scale: 1 or 2) and prehospital return of spontaneous circulation (ROSC). Of the 499 944 patients registered in the database during the study period, 22 877 were included. Among them, 8467 (37.0%) received epinephrine. After time-dependent propensity score-sequential matching, 16 798 patients were included in the matched cohort. In the matched cohort, positive associations were observed between epinephrine and 1-month survival [epinephrine: 17.3% (1454/8399) vs. no epinephrine: 14.6% (1224/8399); RR 1.22 (95% confidence interval, CI: 1.13-1.32)] and prehospital ROSC [epinephrine: 22.2% (1868/8399) vs. no epinephrine: 10.7% (900/8399); RR 2.07 (95% CI: 1.91-2.25)]. No significant positive association was observed between epinephrine and favourable neurological outcome [epinephrine: 7.8% (654/8399) vs. no epinephrine: 7.1% (611/8399); RR 1.13 (95% CI 0.998-1.27)].</p><p><strong>Conclusion: </strong>Using the nationwide population-based registry with time-dependent propensity score-sequential matching analysis, prehospital epinephrine administration in adult OHCA patients with refractory shockable rhythm was positively associated with 1-month survival and prehospital ROSC.</p>","PeriodicalId":11995,"journal":{"name":"European Heart Journal — Cardiovascular Pharmacotherapy","volume":" ","pages":"263-271"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/ehjcvp/pvab013","citationCount":"3","resultStr":"{\"title\":\"Epinephrine administration for adult out-of-hospital cardiac arrest patients with refractory shockable rhythm: time-dependent propensity score-sequential matching analysis from a nationwide population-based registry.\",\"authors\":\"Tasuku Matsuyama,&nbsp;Sho Komukai,&nbsp;Junichi Izawa,&nbsp;Koichiro Gibo,&nbsp;Masashi Okubo,&nbsp;Kosuke Kiyohara,&nbsp;Takeyuki Kiguchi,&nbsp;Taku Iwami,&nbsp;Bon Ohta,&nbsp;Tetsuhisa Kitamura\",\"doi\":\"10.1093/ehjcvp/pvab013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Little is known about the effect of prehospital epinephrine administration in out-of-hospital cardiac arrest (OHCA) patients with refractory shockable rhythm, for whom initial defibrillation was unsuccessful.</p><p><strong>Methods and results: </strong>This study using Japanese nationwide population-based registry included all adult OHCA patients aged ≥18 years with refractory shockable rhythm between January 2014 and December 2017. Patients with or without epinephrine during cardiac arrest were sequentially matched using a risk set matching based on the time-dependent propensity scores within the same minute. The primary outcome was 1-month survival. The secondary outcomes included 1-month survival with favourable neurological outcome (cerebral performance category scale: 1 or 2) and prehospital return of spontaneous circulation (ROSC). Of the 499 944 patients registered in the database during the study period, 22 877 were included. Among them, 8467 (37.0%) received epinephrine. After time-dependent propensity score-sequential matching, 16 798 patients were included in the matched cohort. In the matched cohort, positive associations were observed between epinephrine and 1-month survival [epinephrine: 17.3% (1454/8399) vs. no epinephrine: 14.6% (1224/8399); RR 1.22 (95% confidence interval, CI: 1.13-1.32)] and prehospital ROSC [epinephrine: 22.2% (1868/8399) vs. no epinephrine: 10.7% (900/8399); RR 2.07 (95% CI: 1.91-2.25)]. No significant positive association was observed between epinephrine and favourable neurological outcome [epinephrine: 7.8% (654/8399) vs. no epinephrine: 7.1% (611/8399); RR 1.13 (95% CI 0.998-1.27)].</p><p><strong>Conclusion: </strong>Using the nationwide population-based registry with time-dependent propensity score-sequential matching analysis, prehospital epinephrine administration in adult OHCA patients with refractory shockable rhythm was positively associated with 1-month survival and prehospital ROSC.</p>\",\"PeriodicalId\":11995,\"journal\":{\"name\":\"European Heart Journal — Cardiovascular Pharmacotherapy\",\"volume\":\" \",\"pages\":\"263-271\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1093/ehjcvp/pvab013\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Heart Journal — Cardiovascular Pharmacotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjcvp/pvab013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal — Cardiovascular Pharmacotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ehjcvp/pvab013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

目的:院前肾上腺素给药对院外心脏骤停(OHCA)患者的影响知之甚少,这些患者具有难治性震荡心律,最初的除颤不成功。方法和结果:本研究采用日本全国人口为基础的登记处,包括2014年1月至2017年12月期间所有年龄≥18岁的难治性休克性心律的成年OHCA患者。在心脏骤停期间使用或不使用肾上腺素的患者在同一分钟内使用基于时间依赖性倾向评分的风险集匹配进行顺序匹配。主要终点为1个月生存率。次要结局包括1个月的生存,神经系统预后良好(脑功能分类量表:1或2)和院前自发循环恢复(ROSC)。在研究期间数据库中登记的499 944例患者中,有22 877例被纳入研究。其中8467例(37.0%)接受肾上腺素治疗。经过时间依赖性倾向评分-序列匹配后,16798例患者被纳入匹配队列。在匹配的队列中,肾上腺素与1个月生存率呈正相关[肾上腺素:17.3% (1454/8399)vs.无肾上腺素:14.6% (1224/8399);RR 1.22(95%可信区间,CI: 1.13-1.32),院前ROSC[肾上腺素:22.2% (1868/8399)vs.无肾上腺素:10.7% (900/8399)];Rr 2.07 (95% ci: 1.91-2.25)]。肾上腺素与良好的神经预后之间没有显著的正相关[肾上腺素:7.8% (654/8399)vs.无肾上腺素:7.1% (611/8399);Rr 1.13 (95% ci 0.998-1.27)]。结论:使用基于全国人口的登记和时间依赖倾向评分序列匹配分析,院前给药的难治性休克性心律成人OHCA患者的1个月生存率和院前ROSC呈正相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epinephrine administration for adult out-of-hospital cardiac arrest patients with refractory shockable rhythm: time-dependent propensity score-sequential matching analysis from a nationwide population-based registry.

Aims: Little is known about the effect of prehospital epinephrine administration in out-of-hospital cardiac arrest (OHCA) patients with refractory shockable rhythm, for whom initial defibrillation was unsuccessful.

Methods and results: This study using Japanese nationwide population-based registry included all adult OHCA patients aged ≥18 years with refractory shockable rhythm between January 2014 and December 2017. Patients with or without epinephrine during cardiac arrest were sequentially matched using a risk set matching based on the time-dependent propensity scores within the same minute. The primary outcome was 1-month survival. The secondary outcomes included 1-month survival with favourable neurological outcome (cerebral performance category scale: 1 or 2) and prehospital return of spontaneous circulation (ROSC). Of the 499 944 patients registered in the database during the study period, 22 877 were included. Among them, 8467 (37.0%) received epinephrine. After time-dependent propensity score-sequential matching, 16 798 patients were included in the matched cohort. In the matched cohort, positive associations were observed between epinephrine and 1-month survival [epinephrine: 17.3% (1454/8399) vs. no epinephrine: 14.6% (1224/8399); RR 1.22 (95% confidence interval, CI: 1.13-1.32)] and prehospital ROSC [epinephrine: 22.2% (1868/8399) vs. no epinephrine: 10.7% (900/8399); RR 2.07 (95% CI: 1.91-2.25)]. No significant positive association was observed between epinephrine and favourable neurological outcome [epinephrine: 7.8% (654/8399) vs. no epinephrine: 7.1% (611/8399); RR 1.13 (95% CI 0.998-1.27)].

Conclusion: Using the nationwide population-based registry with time-dependent propensity score-sequential matching analysis, prehospital epinephrine administration in adult OHCA patients with refractory shockable rhythm was positively associated with 1-month survival and prehospital ROSC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信